Medicine Teva Reports Positive Data from Anti-TL1A Antibody for Inflammatory Bowel Diseases February 21, 2024 - By admin TEV-’574 has shown potential as a treatment for inflammatory bowel diseases such as ulcerative colitis and Crohn disease.